ultrasonic-scientific

Soluble Antibody Stimulation as Revealed by BOOST Phosphotyrosine Proteomics

Are chimeric antigen receptor T cells (CAR-T cells) the long run in immunotherapy for autoimmune illnesses?

Goal: CAR-T cell remedy has revolutionized the remedy of oncological illnesses, and potential makes use of in autoimmune illnesses have just lately been described. The overview goals to combine the accessible knowledge on remedy with CAR-T cells, emphasizing autoimmune illnesses, to find out therapeutic advances and their doable future medical applicability in autoimmunity.

Supplies and strategies: A search was carried out in PubMed with the key phrases “Chimeric Antigen Receptor” and “CART cell”. The paperwork of curiosity have been chosen, and a essential overview of the data was carried out.

Outcomes: Within the remedy of autoimmune illnesses, in preclinical fashions, three completely different mobile methods have been used, which embody Chimeric antigen receptor T cells, Chimeric autoantibody receptor T cells, and Chimeric antigen receptor in regulatory T lymphocytes. All three sorts of remedy have been efficient. The potential antagonistic results inside them, cytokine launch syndrome, mobile toxicity and neurotoxicity should all the time be stored in thoughts.

Conclusions: Though info in people just isn’t but accessible, preclinical fashions of CAR-T cells within the remedy of autoimmune illnesses present promising outcomes, in order that sooner or later, they could turn out to be a helpful and efficient remedy within the remedy of those pathologies.

 

Ovalbumin Antigen-Particular Activation of Human T Cell Receptor Carefully Resembles Soluble Antibody Stimulation as Revealed by BOOST Phosphotyrosine Proteomics

Activation of the T cell receptor (TCR) results in a community of early signaling predominantly orchestrated by tyrosine phosphorylation in T cells. The TCR is usually activated utilizing soluble anti-TCR antibodies, however this method just isn’t antigen-specific. Alternatively, activating the TCR utilizing particular antigens of a spread of binding affinities within the type of a peptide-major histocompatibility advanced (pMHC) is presumed to be extra physiological. Nonetheless, because of the lack of wide-scale phosphotyrosine (pTyr) proteomic research straight evaluating anti-TCR antibodies and pMHC, a complete definition of those activated states stays enigmatic.

Elucidation of the tyrosine phosphoproteome utilizing quantitative pTyr proteomics permits a greater understanding of the distinctive options of those activating brokers and the position of ligand binding affinity on signaling. Right here, we apply the just lately established Broad-spectrum Optimization Of Selective Triggering (BOOST) to look at perturbations in tyrosine phosphorylation of human TCR triggered by anti-TCR antibodies and pMHC. Our knowledge reveal that high-affinity ovalbumin (OVA) pMHC activation of the human TCR triggers a largely related, albeit doubtlessly stronger, pTyr-mediated signaling regulatory axis in comparison with the anti-TCR antibody. The signaling output ensuing from OVA pMHC variants correlates properly with their weaker affinities, enabling affinity-tunable management of signaling energy. Collectively, we offer a framework for making use of BOOST to match pTyr-mediated signaling pathways of human T cells activated in an antigen-independent and antigen-specific method.

Bilateral anterior cerebral artery occlusion following CD19- and BCMA-targeted chimeric antigen receptor T-cell remedy for a myeloma affected person

Chimeric antigen receptor T (CAR-T)-cell remedy is a promising remedy for relapsed/refractory a number of myeloma (RRMM). In our earlier report, CD19- and BCMA-targeted CAR-T co-administration was related to a excessive response fee. Though cytokine launch syndrome (CRS) and neurotoxicity are frequent issues following CAR-T remedy, cerebral infarction is never reported as a CAR-T-related complication. We reported a 73-year-old feminine MM affected person who obtained CD19- and BCMA-targeted CAR-T for refractory illness.

Her illness responded to CAR-T remedy, however she developed neurological signs following CRS. Cranial CT and MRI demonstrated a number of cerebral infarctions and bilateral anterior cerebral artery (ACA) occlusion. We propose that cerebral infarction aside from CAR-T-related neurotoxicity is the underlying reason behind irregular neuropsychological signs, and diagnostic imaging assessments must be actively carried out to exclude ischemic cerebrovascular occasions.

ultrasonic-scientific
ultrasonic-scientific

CMV Control lentiviral particles (Neo)

CMV-Null-Neo 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter.

CMV Control lentiviral particles (Puro)

CMV-Null-Puro 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter.

EBAG9 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV694975 1.0 ug DNA
EUR 616.8

CMV Control lentiviral particles (GFP-Bsd)

CMV-Null-GB 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter.

CMV Control lentiviral particles (GFP-Puro)

CMV-Null-GP 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter.

CMV Control lentiviral particles (RFP-Bsd)

CMV-Null-RB 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter.

CMV Control lentiviral particles (RFP-Puro)

CMV-Null-RP 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter.

CMV control lentivirus (Hygro)

CMV-Null-Hygro 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the hygromycin selection under RSV promoter.

CMV control lentivirus (Zeo)

CMV-Null-Zeo 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the Zeocin selection under RSV promoter.

EBAG9 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV709564 1.0 ug DNA
EUR 379.2

EBAG9 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV709565 1.0 ug DNA
EUR 448.8

EBAG9 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV709566 1.0 ug DNA
EUR 448.8

EBAG9 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV694976 1.0 ug DNA
EUR 616.8

EBAG9 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV694977 1.0 ug DNA
EUR 686.4

EBAG9 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV694978 1.0 ug DNA
EUR 686.4

CMV Control lentiviral particles (Bsd) in PBS

CMV-Null-Bsd-PBS 1 x108 IFU/ml x 200ul
EUR 852
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the blasticidin marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (Neo) in PBS

CMV-Null-Neo-PBS 1 x108 IFU/ml x 200ul
EUR 852
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (Puro) in PBS

CMV-Null-Puro-PBS 1 x108 IFU/ml x 200ul
EUR 852
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (GFP-Bsd) in PBS

CMV-Null-GB-PBS 1 x108 IFU/ml x 200ul
EUR 852
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (GFP-Puro) in PBS

CMV-Null-GP-PBS 1 x108 IFU/ml x 200ul
EUR 852
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (RFP-Bsd) in PBS

CMV-Null-RB-PBS 1 x108 IFU/ml x 200ul
EUR 852
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

CMV Control lentiviral particles (RFP-Puro) in PBS

CMV-Null-RP-PBS 1 x108 IFU/ml x 200ul
EUR 852
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution.

EBAG9 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV709567 1.0 ug DNA
EUR 379.2

EBAG9 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV709568 1.0 ug DNA
EUR 379.2

MT1P3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701007 1.0 ug DNA
EUR 540

LOC284297 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701013 1.0 ug DNA
EUR 540

LOC149837 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701019 1.0 ug DNA
EUR 540

GHRLOS2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701025 1.0 ug DNA
EUR 540

LINC00469 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701031 1.0 ug DNA
EUR 540

INGX Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701037 1.0 ug DNA
EUR 540

ABCA11P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701049 1.0 ug DNA
EUR 540

NCOR1P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701061 1.0 ug DNA
EUR 540

ZDHHC8P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701067 1.0 ug DNA
EUR 540

FLJ26850 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701073 1.0 ug DNA
EUR 540

OCLM Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701079 1.0 ug DNA
EUR 540

LINC00314 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701085 1.0 ug DNA
EUR 540

GSTTP1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701091 1.0 ug DNA
EUR 540

LOC285679 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701097 1.0 ug DNA
EUR 540

VN1R3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701103 1.0 ug DNA
EUR 540

MT1DP Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701115 1.0 ug DNA
EUR 540

LINC00313 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701127 1.0 ug DNA
EUR 540

LOC222699 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701139 1.0 ug DNA
EUR 540

LINC00161 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701145 1.0 ug DNA
EUR 540

LOC440419 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701151 1.0 ug DNA
EUR 540

KCNQ1DN Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701157 1.0 ug DNA
EUR 540

RBMS1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701175 1.0 ug DNA
EUR 540

MIR22HG Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701181 1.0 ug DNA Ask for price

C22orf34 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701187 1.0 ug DNA
EUR 540

ZNF663 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701193 1.0 ug DNA
EUR 540

AKR1CL1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701199 1.0 ug DNA
EUR 540

HMGB3P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701205 1.0 ug DNA
EUR 540

ASIP Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701211 1.0 ug DNA
EUR 540

LOC149950 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701217 1.0 ug DNA
EUR 540

BOLA2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701223 1.0 ug DNA
EUR 540

LOC441108 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701229 1.0 ug DNA
EUR 540

FLJ16126 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701235 1.0 ug DNA
EUR 540

LOC728032 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701241 1.0 ug DNA
EUR 540

C21orf67 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701253 1.0 ug DNA
EUR 540

TP53TG3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701259 1.0 ug DNA
EUR 540

OSTBETA Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701265 1.0 ug DNA
EUR 540

FLJ33360 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701271 1.0 ug DNA
EUR 540

LOC441208 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701277 1.0 ug DNA
EUR 540

C12orf36 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701283 1.0 ug DNA
EUR 540

LOC153684 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701289 1.0 ug DNA
EUR 540

LOC399900 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701295 1.0 ug DNA
EUR 540

LOC149134 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701301 1.0 ug DNA
EUR 540

LINC00173 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701313 1.0 ug DNA
EUR 540

LITAF Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701319 1.0 ug DNA
EUR 540

HIST1H2AI Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701325 1.0 ug DNA
EUR 540

LOC440905 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701331 1.0 ug DNA
EUR 540

LOC339535 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701337 1.0 ug DNA
EUR 540

LOC643210 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701343 1.0 ug DNA
EUR 540

LOC440337 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701349 1.0 ug DNA
EUR 540

BEX1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701355 1.0 ug DNA
EUR 540

HIST2H2AA4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701361 1.0 ug DNA
EUR 540

LPAL2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701367 1.0 ug DNA
EUR 540

LOC340094 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701373 1.0 ug DNA
EUR 540

LINC00574 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701379 1.0 ug DNA
EUR 540

CIB2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701385 1.0 ug DNA
EUR 540

SNX12 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701397 1.0 ug DNA
EUR 540

FLJ44006 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701403 1.0 ug DNA
EUR 540

C15orf37 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701409 1.0 ug DNA
EUR 540

PLAC2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701415 1.0 ug DNA
EUR 540

BTG2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701421 1.0 ug DNA
EUR 540

FLJ40448 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701445 1.0 ug DNA
EUR 540

CIB3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701451 1.0 ug DNA
EUR 540

PRDX5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701457 1.0 ug DNA
EUR 540

FLJ45256 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701463 1.0 ug DNA
EUR 540

C21orf67 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701469 1.0 ug DNA
EUR 540

LINC00477 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701475 1.0 ug DNA
EUR 540

LOC348262 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701487 1.0 ug DNA
EUR 540

SHISA4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701493 1.0 ug DNA
EUR 540

LOC400707 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701499 1.0 ug DNA
EUR 540

FLJ41423 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701505 1.0 ug DNA
EUR 540

FLJ46257 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701511 1.0 ug DNA
EUR 540

FKSG83 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701517 1.0 ug DNA
EUR 540

FLJ25328 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701523 1.0 ug DNA
EUR 540

LOC84931 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701529 1.0 ug DNA
EUR 540

LOC389791 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701535 1.0 ug DNA
EUR 540

LOC338809 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701541 1.0 ug DNA
EUR 540

LOC441251 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701553 1.0 ug DNA
EUR 540

INSL6 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701559 1.0 ug DNA
EUR 540

C1orf222 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701565 1.0 ug DNA
EUR 540

SFTPA2B Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701571 1.0 ug DNA
EUR 540

CCDC102B Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701595 1.0 ug DNA
EUR 540

C1QTNF3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701601 1.0 ug DNA
EUR 540

OTOGL Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701607 1.0 ug DNA
EUR 540

LHPP Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701613 1.0 ug DNA
EUR 540

TICAM2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701619 1.0 ug DNA
EUR 540

CHMP4A Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701625 1.0 ug DNA
EUR 540

ALKBH3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701631 1.0 ug DNA
EUR 540

FBP2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701637 1.0 ug DNA
EUR 540

CLEC12A Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701643 1.0 ug DNA
EUR 540

OR2C1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701649 1.0 ug DNA
EUR 540

TMEM182 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701655 1.0 ug DNA
EUR 540

LOC339524 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701661 1.0 ug DNA
EUR 540

SEPSECS Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701667 1.0 ug DNA
EUR 540

Selv Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701673 1.0 ug DNA
EUR 540

GPR87 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701679 1.0 ug DNA
EUR 540

ASTN2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701685 1.0 ug DNA
EUR 540

MAGEB3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701691 1.0 ug DNA
EUR 540

SSTr4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701709 1.0 ug DNA
EUR 540

ACOT4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701715 1.0 ug DNA
EUR 540

ZNF672 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701721 1.0 ug DNA
EUR 540

SLC16A3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701727 1.0 ug DNA
EUR 540

CTBS Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701739 1.0 ug DNA
EUR 540

APOL1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701745 1.0 ug DNA
EUR 540

ST8SIA1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701751 1.0 ug DNA
EUR 540

MTERF Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701757 1.0 ug DNA
EUR 540

ALG13 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701763 1.0 ug DNA
EUR 540

ATF2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701769 1.0 ug DNA
EUR 540

AHCYL1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701775 1.0 ug DNA
EUR 540

ZKSCAN1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701781 1.0 ug DNA
EUR 540

PTH1R Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701787 1.0 ug DNA
EUR 540

LOC553158 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701793 1.0 ug DNA
EUR 540

PIK3R2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701799 1.0 ug DNA
EUR 540

EBF3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701805 1.0 ug DNA
EUR 540

R3HDM2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701811 1.0 ug DNA
EUR 540

KCNN2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701817 1.0 ug DNA
EUR 540

SPIRE1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701823 1.0 ug DNA
EUR 540

TTC26 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701835 1.0 ug DNA
EUR 540

ARSJ Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701841 1.0 ug DNA
EUR 540

SNX18 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701847 1.0 ug DNA
EUR 540

PYHIN1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701853 1.0 ug DNA
EUR 540

ZNF587 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701859 1.0 ug DNA
EUR 540

CDADC1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701865 1.0 ug DNA
EUR 540

FIP1L1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701871 1.0 ug DNA
EUR 540

GALNT3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701877 1.0 ug DNA
EUR 540

P4HA3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701889 1.0 ug DNA
EUR 540

IFFO1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701895 1.0 ug DNA
EUR 540

GRAMD4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701901 1.0 ug DNA
EUR 540

ZNF254 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701907 1.0 ug DNA
EUR 540

IREB2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701919 1.0 ug DNA
EUR 540

RBM26 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701925 1.0 ug DNA
EUR 540

ZBTB24 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701931 1.0 ug DNA
EUR 540

NLGN4Y Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701937 1.0 ug DNA
EUR 540

HSPA4 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701943 1.0 ug DNA
EUR 540

GRM2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701949 1.0 ug DNA
EUR 540

EphA7 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701955 1.0 ug DNA
EUR 540

TUT1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701967 1.0 ug DNA
EUR 540

PKD2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701973 1.0 ug DNA
EUR 540

HGF Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701979 1.0 ug DNA
EUR 540

MCTP2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701985 1.0 ug DNA
EUR 540

STON2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701991 1.0 ug DNA
EUR 540

C17orf70 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV701997 1.0 ug DNA
EUR 540

The Intracellular Area of CD40 is a Potent Costimulatory Component in Chimeric Antigen Receptors

The costimulatory domains included into second-generation and third-generation chimeric antigen receptors (CARs) strongly affect CAR-T-cell operate. Right here, we explored second-generation and third-generation CARs harboring the signaling area of the CD40 receptor as a brand new costimulatory aspect as compared with related CARs carrying the 4-1BB area. In CARs of each generations, CD40 was stronger than 4-1BB in triggering the NF-κB signaling pathway.

In human T cells from 2 donors, CD40 was akin to 4-1BB in upregulating costimulatory and activation markers, inducing proinflammatory cytokine secretion and mediating goal cell killing. Apparently, variations within the response sample of T cells from the two donors with respect to CD40 and 4-1BB have been evident. We conclude that in human T cells, the CD40 signaling area is a potent costimulatory aspect in each second-generation and third-generation CARs.

A Systematic Overview of the Function of Chimeric Antigen Receptor T (CAR-T) Cell Remedy within the Therapy of Strong Tumors

Chimeric antigen receptor T (CAR-T) cell remedy makes use of sufferers’ personal T lymphocytes which might be engineered to assault most cancers cells. It’s Meals and Drug Administration (FDA)-approved in numerous hematological malignancies and presently being evaluated in strong cancers in early section research. We did a scientific overview consisting of 15 potential medical trials (n=159) evaluating CAR-T cells in strong cancers. Early section trials confirmed promising response charges in ovarian epithelial most cancers (100%), human epidermal progress issue receptor 2 (HER2)-positive sarcoma (67%), epidermal progress issue receptor (EGFR)-positive biliary tract most cancers (65%), superior gastric/pancreatic most cancers (82%), hepatocellular carcinoma (67%), and colorectal most cancers (70%).

The median general response throughout all malignancies was 62% (vary 17%-100%). Median progression-free survival and general survival weren’t reached in most trials. Cytokine launch syndrome was seen in just one affected person with cholangiocarcinoma who obtained EGFR-specific CAR-T cell remedy. Though survival knowledge continues to be not mature, CAR-T cell remedy in strong malignancies did present encouraging response charges and was well-tolerated.

Variations in lymphoma sufferers between chimeric antigen receptor T-cell remedy trials and the overall inhabitants

Chimeric antigen receptor (CAR)-T cell therapies seem to be promising therapies for non-Hodgkin’s and B-cell lymphoma. Nonetheless, a number of CAR-T therapies accredited by the US Meals and Drug Administration have solely been examined for efficacy in comparatively few single-arm medical trials with small pattern sizes. We sought to look at the variations between sufferers in these trials and the overall inhabitants of sufferers with non-Hodgkin’s and B-cell lymphoma. 5 hundred and twenty-two sufferers from 15 CAR-T trials present in a scientific overview and 417,492 sufferers from the Surveillance, Epidemiology, and Finish Outcomes (SEER) Program database have been in contrast.

CAR-T research individuals seemed to be youthful (46.7% beneath 70 years previous vs. 42.2%), extra male (68.0% vs. 55.7%), and adopted for a shorter time period in comparison with sufferers within the SEER inhabitants (imply [M] 45.6 months, 95% confidence interval [CI] 17.7 to 63.three months follow-up vs. M 57.1 months, 95% CI 57.Zero to 57.three months survival). CAR-T research individuals might differ considerably from the overall inhabitants of sufferers with non-Hodgkin’s and B-cell lymphoma. Effectiveness of CAR-T therapies within the common inhabitants of lymphoma sufferers might differ from effectiveness demonstrated in trials. Newly created CAR-T affected person registries are important to establishing population-level effectiveness of the therapies.

Recombinant Human ITGB1 Protein, His, E.coli-2ug

QP12462-HIS-2ug 2ug
EUR 186

Recombinant Human ITGB1 Protein, His, E.coli-5ug

QP12462-HIS-5ug 5ug
EUR 186

Recombinant Human ITGB1 Protein, His, E.coli-1mg

QP12462-HIS-EC-1mg 1mg
EUR 3308.4

ITGB1 protein (His tag)

80R-3617 100 ug
EUR 392.4
Description: Purified recombinant ITGB1 protein (His tag)

Human Integrin Beta 1 (ITGb1) ELISA Kit

DLR-ITGb1-Hu-48T 48T
EUR 597.6
Description: A sandwich quantitative ELISA assay kit for detection of Human Integrin Beta 1 (ITGb1) in samples from tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human Integrin Beta 1 (ITGb1) ELISA Kit

DLR-ITGb1-Hu-96T 96T
EUR 776.4
Description: A sandwich quantitative ELISA assay kit for detection of Human Integrin Beta 1 (ITGb1) in samples from tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human Integrin Beta 1 (ITGb1) ELISA Kit

RD-ITGb1-Hu-48Tests 48 Tests
EUR 600

Human Integrin Beta 1 (ITGb1) ELISA Kit

RD-ITGb1-Hu-96Tests 96 Tests
EUR 830.4

Human Integrin Beta 1 (ITGb1) ELISA Kit

RDR-ITGb1-Hu-48Tests 48 Tests
EUR 626.4

Human Integrin Beta 1 (ITGb1) ELISA Kit

RDR-ITGb1-Hu-96Tests 96 Tests
EUR 868.8

Recombinant Human ITGB1 Protein, His, Insect-1mg

QP12462-HIS-INSECT-1mg 1mg
EUR 6301.2

Recombinant (E.coli) Human CD40 (aa: 21-193, His Tag, >95% Pure)

HCD4015-N-10 10 ug
EUR 343.2

XMIR-21 RNA oligo miRNA-21-5p with Xmotif

XMIR-21 10 rxn
EUR 525.6

AXMIR-21 RNA oligo anti-miRNA-21-5p with Xmotif

AXMIR-21 10 reactions
EUR 525.6

Recombinant (E.Coli, His-tag) Human Syndecan-4, His-tag

RP-993 10 ug
EUR 270

ICP Quality Control Standard 21

QC-21 125ML
EUR 337.44

Recombinant (E.coli) Rat CD40 (aa: 21-193, His Tag, >95% Pure)

RCD4015-N-10 10 ug
EUR 255.6

FGF-21 Fibroblast Growth Factor-21 Human Recombinant Protein, His Tag

PROTQ9NSA1 Regular: 50ug
EUR 380.4
Description: Fibroblast Growth Factor -21 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 202 amino acids (29-209) and having a molecular mass of 21.6 kDa (molecular weight on SDS-PAGE will appear higher). ;The FGF-21 is fused to a 20 amino acid His Tag at N-terminus and purified by proprietary chromatographic techniques.

Recombinant (E.Coli, His-tag) Human HTRA2

RP-413 10 ug
EUR 270

Recombinant (E.Coli, His-tag) Human STAT1

RP-722 10 ug
EUR 343.2

Recombinant (E.Coli, His-tag) Human S100b

RP-774 10 ug
EUR 343.2

Recombinant (E.Coli, His-tag) Human Osteocrin

RP-868 10 ug
EUR 343.2

Recombinant (E.Coli, His-tag) Human CD29

RP-915 2 ug
EUR 416.4

Recombinant (E.Coli, His-tag) Human Geminin

RP-989 5 ug
EUR 196.8

Recombinant Human Fibroblast Growth Factor-21, His Tag

7-00385 10µg Ask for price

Recombinant Human Fibroblast Growth Factor-21, His Tag

7-00386 50µg Ask for price

Recombinant Human Fibroblast Growth Factor-21, His Tag

7-00387 1mg Ask for price

XMIRXpress lentivector miRNA-21-5p with Xmotif

XMIRXP-21 10 ug
EUR 812.4

Recombinant E.coli LACTB Protein, His, E.coli-20ug

QP12522-HIS-20ug 20ug
EUR 241.2

Recombinant E.coli LACTB Protein, His, E.coli-5ug

QP12522-HIS-5ug 5ug
EUR 186

Recombinant (E.Coli, His-tag) Human Ubiquitin Conjugating enzyme 7, His-tag

RP-425 10 ug
EUR 270

Histidine-tag (poly-His/Hisx6) Protein (His-tag-fusion protein) ELISA Kit, 96 tests, Quantitative

800-440-HIS 1 kit
EUR 1074

Recombinant Human ACPP Protein, His, E.coli-100ug

QP10946-HIS-100ug 100ug
EUR 1513.2

Recombinant Human ACPP Protein, His, E.coli-10ug

QP10946-HIS-10ug 10ug
EUR 241.2

Recombinant Human ACPP Protein, His, E.coli-1mg

QP10946-HIS-1mg 1mg
EUR 4386

Recombinant Human ACPP Protein, His, E.coli-20ug

QP10946-HIS-20ug 20ug
EUR 241.2

Recombinant Human ACPP Protein, His, E.coli-2ug

QP10946-HIS-2ug 2ug
EUR 186

Recombinant Human ACPP Protein, His, E.coli-5ug

QP10946-HIS-5ug 5ug
EUR 186

Recombinant Human ADAM10 Protein, His, E.coli-10ug

QP10961-HIS-10ug 10ug
EUR 241.2

Recombinant Human ADAM10 Protein, His, E.coli-1mg

QP10961-HIS-1mg 1mg
EUR 5821.2

Recombinant Human ADAM10 Protein, His, E.coli-1ug

QP10961-HIS-1ug 1ug
EUR 186

Recombinant Human ADAM10 Protein, His, E.coli-2ug

QP10961-HIS-2ug 2ug
EUR 186

Recombinant Human ADAM10 Protein, His, E.coli-50ug

QP10961-HIS-50ug 50ug
EUR 1513.2

Recombinant Human ADAM10 Protein, His, E.coli-5ug

QP10961-HIS-5ug 5ug
EUR 241.2

Recombinant Human ADH1A Protein, His, E.coli-10ug

QP10966-HIS-10ug 10ug
EUR 241.2

Recombinant Human ADH1A Protein, His, E.coli-20ug

QP10966-HIS-20ug 20ug
EUR 241.2

Recombinant Human ADH1A Protein, His, E.coli-2ug

QP10966-HIS-2ug 2ug
EUR 186

Recombinant Human ADH1A Protein, His, E.coli-5ug

QP10966-HIS-5ug 5ug
EUR 186

Recombinant Human Adipsin Protein, His, E.coli-10ug

QP10969-HIS-10ug 10ug
EUR 241.2

Recombinant Human Adipsin Protein, His, E.coli-20ug

QP10969-HIS-20ug 20ug
EUR 241.2

Recombinant Human Adipsin Protein, His, E.coli-2ug

QP10969-HIS-2ug 2ug
EUR 186

Recombinant Human Adipsin Protein, His, E.coli-5ug

QP10969-HIS-5ug 5ug
EUR 186

Recombinant Human AKR1D1 Protein, His, E.coli-20ug

QP10995-HIS-20ug 20ug
EUR 241.2

Recombinant Human AKR1D1 Protein, His, E.coli-5ug

QP10995-HIS-5ug 5ug
EUR 186

Recombinant Human AMBP Protein, His, E.coli-10ug

QP11009-HIS-10ug 10ug
EUR 241.2

Recombinant Human AMBP Protein, His, E.coli-1mg

QP11009-HIS-1mg 1mg
EUR 6301.2

Recombinant Human AMBP Protein, His, E.coli-2ug

QP11009-HIS-2ug 2ug
EUR 186

Recombinant Human ANGPTL3 Protein, His, E.coli-100ug

QP11018-HIS-100ug 100ug
EUR 1513.2

Recombinant Human ANGPTL3 Protein, His, E.coli-1mg

QP11018-HIS-1mg 1mg
EUR 5821.2

Recombinant Human APOA5 Protein, His, E.coli-2ug

QP11046-HIS-2ug 2ug
EUR 186

Recombinant Human ATP1B1 Protein, His, E.coli-10ug

QP11104-HIS-10ug 10ug
EUR 241.2

Recombinant Human ATP1B1 Protein, His, E.coli-20ug

QP11104-HIS-20ug 20ug
EUR 241.2

Recombinant Human ATP1B1 Protein, His, E.coli-2ug

QP11104-HIS-2ug 2ug
EUR 186

Recombinant Human ATP1B1 Protein, His, E.coli-5ug

QP11104-HIS-5ug 5ug
EUR 186

Recombinant Human ATP1B2 Protein, His, E.coli-10ug

QP11105-HIS-10ug 10ug
EUR 241.2

Recombinant Human ATP1B2 Protein, His, E.coli-20ug

QP11105-HIS-20ug 20ug
EUR 241.2

Recombinant Human ATP1B2 Protein, His, E.coli-2ug

QP11105-HIS-2ug 2ug
EUR 186

Recombinant Human ATP1B2 Protein, His, E.coli-5ug

QP11105-HIS-5ug 5ug
EUR 186

Recombinant Human AZGP1 Protein, His, E.coli-1mg

QP11114-HIS-1mg 1mg
EUR 4386

Recombinant Human AZGP1 Protein, His, E.coli-20ug

QP11114-HIS-20ug 20ug
EUR 241.2

Recombinant Human AZGP1 Protein, His, E.coli-5ug

QP11114-HIS-5ug 5ug
EUR 186

Recombinant Human B2M Protein, His, E.coli-1ug

QP11117-HIS-1ug 1ug
EUR 186

Recombinant Human B2M Protein, His, E.coli-50ug

QP11117-HIS-50ug 50ug
EUR 1393.2

Recombinant Human B2M Protein, His, E.coli-5ug

QP11117-HIS-5ug 5ug
EUR 241.2

Recombinant Human BIRC7 Protein, His, E.coli-20ug

QP11164-HIS-20ug 20ug
EUR 241.2

Recombinant Human BIRC7 Protein, His, E.coli-5ug

QP11164-HIS-5ug 5ug
EUR 186

Recombinant Human IGFBP7 Protein, His, E.coli-100ug

QP12384-HIS-100ug 100ug
EUR 1513.2

Recombinant Human IGFBP7 Protein, His, E.coli-10ug

QP12384-HIS-10ug 10ug
EUR 241.2

Recombinant Human IGFBP7 Protein, His, E.coli-2ug

QP12384-HIS-2ug 2ug
EUR 186

Recombinant Human IL13RA2 Protein, His, E.coli-10ug

QP12406-HIS-10ug 10ug
EUR 241.2

Recombinant Human IL13RA2 Protein, His, E.coli-20ug

QP12406-HIS-20ug 20ug
EUR 241.2

Recombinant Human IL13RA2 Protein, His, E.coli-2ug

QP12406-HIS-2ug 2ug
EUR 186

Recombinant Human IL13RA2 Protein, His, E.coli-5ug

QP12406-HIS-5ug 5ug
EUR 186

Recombinant Human KLF4 Protein, His, E.coli-20ug

QP12498-HIS-20ug 20ug
EUR 241.2

Recombinant Human KLF4 Protein, His, E.coli-5ug

QP12498-HIS-5ug 5ug
EUR 186

Recombinant Human KLK15 Protein, His, E.coli-1mg

QP12504-HIS-1mg 1mg
EUR 3308.4

Recombinant Human KLK15 Protein, His, E.coli-1ug

QP12504-HIS-1ug 1ug
EUR 186

Recombinant Human KLK15 Protein, His, E.coli-20ug

QP12504-HIS-20ug 20ug
EUR 241.2

Recombinant Human KLK15 Protein, His, E.coli-50ug

QP12504-HIS-50ug 50ug
EUR 1513.2

Recombinant Human KLK2 Protein, His, E.coli-1mg

QP12505-HIS-1mg 1mg
EUR 3308.4

Recombinant Human KLK2 Protein, His, E.coli-1ug

QP12505-HIS-1ug 1ug
EUR 186

Recombinant Human KLK2 Protein, His, E.coli-20ug

QP12505-HIS-20ug 20ug
EUR 241.2

Recombinant Human KLK2 Protein, His, E.coli-50ug

QP12505-HIS-50ug 50ug
EUR 1393.2

Recombinant Human KLK3 Protein, His, E.coli-1mg

QP12506-HIS-1mg 1mg
EUR 3308.4

Recombinant Human KLK3 Protein, His, E.coli-20ug

QP12506-HIS-20ug 20ug
EUR 241.2

Recombinant Human KLK3 Protein, His, E.coli-5ug

QP12506-HIS-5ug 5ug
EUR 186

Recombinant Human KLK5 Protein, His, E.coli-100ug

QP12507-HIS-100ug 100ug
EUR 1513.2

Recombinant Human KLK5 Protein, His, E.coli-1mg

QP12507-HIS-1mg 1mg
EUR 6301.2

Recombinant Human KLRB1 Protein, His, E.coli-1mg

QP12508-HIS-1mg 1mg
EUR 3308.4

Recombinant Human KLRB1 Protein, His, E.coli-1ug

QP12508-HIS-1ug 1ug
EUR 186

Recombinant Human KLRB1 Protein, His, E.coli-20ug

QP12508-HIS-20ug 20ug
EUR 241.2

Recombinant Human KLRB1 Protein, His, E.coli-50ug

QP12508-HIS-50ug 50ug
EUR 1513.2

Recombinant Human LHRH Protein, His, E.coli-1mg

QP12569-HIS-1mg 1mg
EUR 4386

Recombinant Human LHRH Protein, His, E.coli-20ug

QP12569-HIS-20ug 20ug
EUR 241.2

Recombinant Human LHRH Protein, His, E.coli-5ug

QP12569-HIS-5ug 5ug
EUR 186

Recombinant Human LIN28 Protein, His, E.coli-10ug

QP12571-HIS-10ug 10ug
EUR 241.2

Recombinant Human LIN28 Protein, His, E.coli-2ug

QP12571-HIS-2ug 2ug
EUR 186

Recombinant Human LIPG Protein, His, E.coli-10ug

QP12577-HIS-10ug 10ug
EUR 241.2

Recombinant Human LIPG Protein, His, E.coli-20ug

QP12577-HIS-20ug 20ug
EUR 241.2

Recombinant Human LIPG Protein, His, E.coli-2ug

QP12577-HIS-2ug 2ug
EUR 186

Recombinant Human LIPG Protein, His, E.coli-5ug

QP12577-HIS-5ug 5ug
EUR 186

Recombinant Human LPL Protein, His, E.coli-10ug

QP12581-HIS-10ug 10ug
EUR 241.2

Recombinant Human LPL Protein, His, E.coli-1mg

QP12581-HIS-1mg 1mg
EUR 6301.2

Recombinant Human LPL Protein, His, E.coli-2ug

QP12581-HIS-2ug 2ug
EUR 186

Recombinant Human LRG1 Protein, His, E.coli-1mg

QP12583-HIS-1mg 1mg
EUR 3308.4

Recombinant Human LRG1 Protein, His, E.coli-20ug

QP12583-HIS-20ug 20ug
EUR 241.2

Recombinant Human LRG1 Protein, His, E.coli-5ug

QP12583-HIS-5ug 5ug
EUR 186

Recombinant Human LUM Protein, His, E.coli-10ug

QP12598-HIS-10ug 10ug
EUR 241.2

Recombinant Human LUM Protein, His, E.coli-20ug

QP12598-HIS-20ug 20ug
EUR 241.2

Recombinant Human LUM Protein, His, E.coli-2ug

QP12598-HIS-2ug 2ug
EUR 186

Recombinant Human LUM Protein, His, E.coli-5ug

QP12598-HIS-5ug 5ug
EUR 186

Recombinant Human LYVE1 Protein, His, E.coli-1mg

QP12609-HIS-1mg 1mg
EUR 6301.2

Recombinant Human MAPK1 Protein, His, E.coli-1mg

QP12639-HIS-1mg 1mg
EUR 2774.4

Recombinant Human MAPK1 Protein, His, E.coli-25ug

QP12639-HIS-25ug 25ug
EUR 241.2

Recombinant Human MAPK1 Protein, His, E.coli-5ug

QP12639-HIS-5ug 5ug
EUR 186

Recombinant Human MFAP4 Protein, His, E.coli-10ug

QP12691-HIS-10ug 10ug
EUR 241.2

Recombinant Human MFAP4 Protein, His, E.coli-20ug

QP12691-HIS-20ug 20ug
EUR 241.2

Recombinant Human MFAP4 Protein, His, E.coli-2ug

QP12691-HIS-2ug 2ug
EUR 186

Recombinant Human MFAP4 Protein, His, E.coli-5ug

QP12691-HIS-5ug 5ug
EUR 186

Recombinant Human NARS Protein, His, E.coli-100ug

QP12794-HIS-100ug 100ug
EUR 1513.2

Recombinant Human NARS Protein, His, E.coli-1mg

QP12794-HIS-1mg 1mg
EUR 6301.2

Recombinant Human NXPH1 Protein, His, E.coli-10ug

QP12912-HIS-10ug 10ug
EUR 241.2

Recombinant Human NXPH1 Protein, His, E.coli-20ug

QP12912-HIS-20ug 20ug
EUR 241.2

Recombinant Human NXPH1 Protein, His, E.coli-2ug

QP12912-HIS-2ug 2ug
EUR 186

Recombinant Human NXPH1 Protein, His, E.coli-5ug

QP12912-HIS-5ug 5ug
EUR 186

Recombinant Human PDCD1LG2 Protein, His, E.coli-10ug

QP12985-HIS-10ug 10ug
EUR 241.2

Recombinant Human PDCD1LG2 Protein, His, E.coli-20ug

QP12985-HIS-20ug 20ug
EUR 241.2

Recombinant Human PDCD1LG2 Protein, His, E.coli-2ug

QP12985-HIS-2ug 2ug
EUR 186

Recombinant Human PDCD1LG2 Protein, His, E.coli-5ug

QP12985-HIS-5ug 5ug
EUR 186

Recombinant Human PEDF Protein, His, E.coli-1mg

QP13005-HIS-1mg 1mg
EUR 3667.2

Recombinant Human PEDF Protein, His, E.coli-20ug

QP13005-HIS-20ug 20ug
EUR 241.2

Recombinant Human PEDF Protein, His, E.coli-5ug

QP13005-HIS-5ug 5ug
EUR 186

Recombinant Human PSG1 Protein, His, E.coli-10ug

QP13179-HIS-10ug 10ug
EUR 241.2

Recombinant Human PSG1 Protein, His, E.coli-20ug

QP13179-HIS-20ug 20ug
EUR 241.2

Recombinant Human PSG1 Protein, His, E.coli-2ug

QP13179-HIS-2ug 2ug
EUR 186

Recombinant Human PSG1 Protein, His, E.coli-5ug

QP13179-HIS-5ug 5ug
EUR 186

Recombinant Human PSG5 Protein, His, E.coli-1mg

QP13180-HIS-1mg 1mg
EUR 3308.4

Recombinant Human PSG5 Protein, His, E.coli-1ug

QP13180-HIS-1ug 1ug
EUR 186

Recombinant Human PSG5 Protein, His, E.coli-20ug

QP13180-HIS-20ug 20ug
EUR 241.2

Recombinant Human PSG5 Protein, His, E.coli-50ug

QP13180-HIS-50ug 50ug
EUR 1393.2

Recombinant Human PTEN Protein, His, E.coli-100ug

QP13199-HIS-0.1mg 100ug
EUR 1698

Recombinant Human PTEN Protein, His, E.coli-1ug

QP13199-HIS-1ug 1ug
EUR 186

Recombinant Human PTX3 Protein, His, E.coli-10ug

QP13217-HIS-10ug 10ug
EUR 241.2

Recombinant Human PTX3 Protein, His, E.coli-20ug

QP13217-HIS-20ug 20ug
EUR 241.2

Recombinant Human PTX3 Protein, His, E.coli-2ug

QP13217-HIS-2ug 2ug
EUR 186

Recombinant Human PTX3 Protein, His, E.coli-5ug

QP13217-HIS-5ug 5ug
EUR 186

Recombinant Human RBP4 Protein, His, E.coli-10ug

QP13283-HIS-10ug 10ug
EUR 241.2

Recombinant Human RBP4 Protein, His, E.coli-2ug

QP13283-HIS-2ug 2ug
EUR 186

Recombinant Human REN Protein, His, E.coli-10ug

QP13296-HIS-10ug 10ug
EUR 241.2

Recombinant Human REN Protein, His, E.coli-25ug

QP13296-HIS-25ug 25ug
EUR 241.2

Recombinant Human REN Protein, His, E.coli-2ug

QP13296-HIS-2ug 2ug
EUR 186

Recombinant Human REN Protein, His, E.coli-5ug

QP13296-HIS-5ug 5ug
EUR 186

Recombinant Human RLBP1 Protein, His, E.coli-10ug

QP13321-HIS-10ug 10ug
EUR 241.2

Recombinant Human RLBP1 Protein, His, E.coli-20ug

QP13321-HIS-20ug 20ug
EUR 241.2

Recombinant Human RLBP1 Protein, His, E.coli-2ug

QP13321-HIS-2ug 2ug
EUR 186

Recombinant Human RLBP1 Protein, His, E.coli-5ug

QP13321-HIS-5ug 5ug
EUR 186

Recombinant Human RLN2 Protein, His, E.coli-1mg

QP13322-HIS-1mg 1mg
EUR 3308.4

Recombinant Human RLN2 Protein, His, E.coli-1ug

QP13322-HIS-1ug 1ug
EUR 186

Recombinant Human RLN2 Protein, His, E.coli-25ug

QP13322-HIS-25ug 25ug
EUR 241.2

Recombinant Human RLN2 Protein, His, E.coli-50ug

QP13322-HIS-50ug 50ug
EUR 1273.2

Recombinant Human RNASE3 Protein, His, E.coli-10ug

QP13323-HIS-10ug 10ug
EUR 241.2

Recombinant Human RNASE3 Protein, His, E.coli-20ug

QP13323-HIS-20ug 20ug
EUR 241.2

Recombinant Human RNASE3 Protein, His, E.coli-2ug

QP13323-HIS-2ug 2ug
EUR 186

Recombinant Human RNASE3 Protein, His, E.coli-5ug

QP13323-HIS-5ug 5ug
EUR 186

Recombinant Human S100A8 Protein, His, E.coli-10ug

QP13399-HIS-10ug 10ug
EUR 241.2

Leave a Reply

Your email address will not be published. Required fields are marked *